SCHEMBL1494675

SCHEMBL1494675

CC(CNc1nccc(-c2[nH]c(C3(C)CC3)nc2Br)n1)NC(=O)O

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BRAF P15056 20/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6525655 0.91 BRAF (0.63) BRAF
SCHEMBL6525657 0.91 BRAF (0.63) BRAF
SCHEMBL6522934 0.84 BRAF (0.43) BRAF
SCHEMBL6522717 0.84 BRAF (0.43) BRAF
SCHEMBL1074443 0.82 BRAF (0.53) BRAF
SCHEMBL12830992 0.79 BRAF (0.44) BRAF
SCHEMBL1494641 0.76 BRAF (0.59) BRAF
SCHEMBL6522901 0.76 BRAF (0.78) BRAF
SCHEMBL1494674 0.75 BRAF (0.79) BRAF
SCHEMBL16105847 0.75 BRAF (0.79) BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2470528-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS Novartis AG (CH) 2012-07-04 EP disclosed
WO-2011023773-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS NOVARTIS AG (CH) 2011-03-03 WO disclosed